Abstract: A compound having formula (2): ##STR1## wherein R represents hydrogen, a straight or branched C.sub.1-10 alkyl group, a C.sub.7-11 aralkyl group or a C.sub.2-10 carboacyl group and m stands for 1 to 5.

Abstract: An object of the invention is to provide a highly characteristic image using an electrophotographic photoreceptor of which a charge-generating layer can be produced with a better coating property and which is highly sensitive and electrostatically highly stable in repeated use. The charge-generating layer of a function-separated type photoreceptor contains a n-type non-metallic phthalocyanine and a copolymer of vinyl chloride-vinyl acetate type. Particularly, the ratio of the .tau.-type non-metallic phthalocyanine to the copolymer of vinyl chloride-vinyl acetate type is fixed at 1/3-3/1 by weight. The thickness of the charge-generating layer is fixed at 0.1-0.6 .mu.m. As the copolymer of vinyl chloride-vinyl acetate type, copolymers of vinyl chloride-vinyl acetate, vinyl chloride-vinyl acetate-maleic acid, or vinyl chloride-vinyl acetate-vinyl alcohol are selected. Particularly, it is favorable to select those containing at least 10% by weight of the vinyl alcohol component.

Abstract: Described is a triazole derivative represented by the formula (1): wherein R.sup.1 represents a hydrogen atom, a lower alkyl group or an aralkyl group, X.sup.1 and X.sup.2 are the same or different and each independently represents a hydrogen atom, a halogen atom or a halogenoalkyl and n stands for an integer of 0 to 2, or salt thereof; a preparation process of said compound and a pharmaceutical comprising said compound as an effective ingredient.The compound as described above has high antimycotic activity and is useful for the prevention and treatment of mammalian mycotic infections.

Abstract: Described is a triazole derivative represented by the formula (1): ##STR1## wherein R.sup.1 represents a lower alkyl group or an aralkyl group, R.sup.2 represents a hydrogen atom, a lower alkyl group, an aralkyl group or an acyl group, X.sup.1 and X.sup.2 are the same or different and each independently represents a hydrogen atom, a halogen atom or a trifluoromethyl group, n stands for an integer of 0 to 2 and m stands for an integer of 1 to 5, or salt thereof; and also a pharmaceutical comprising the derivative or salt thereof as an effective ingredient. The compound as described above has a high antimycotic activity and is useful for the prevention and treatment of mammalian mycotic infections.

Abstract: Described is a triazole derivative represented by the formula (1) or salt thereof, preparation process thereof, preparation intermediates represented by the formulas (2) and (3), and a pharmaceutical comprising the compound represented by the formula (1) or salt thereof. ##STR1## wherein n stands for 0, 1 or 2, X.sup.1 represents H or F and Y.sup.1 and Y.sup.2 each independently represents H, halogen or CF.sub.3.

Abstract: Described is a triazole derivative represented by the formula (1) or salt thereof, preparation process thereof, preparation intermediates represented by the formulas (2) and (3), and a pharmaceutical comprising the compound represented by the formula (1) or salt thereof. wherein n stands for 0, 1 or 2, X.sup.1 represents H or F and Y.sup.1 and Y.sup.2 each independently represents H, halogen or CF.sub.3.

Abstract: Described is a triazole derivative represented by the formula (1) or salt thereof, preparation process thereof, preparation intermediates represented by the formulas (2) and (3), and a pharmaceutical comprising the compound represented by the formula (1) or salt thereof. ##STR1## wherein n stands for 0, 1 or 2, X.sup.1 represents H or F and Y.sup.1 and Y.sup.2 each independently represents H, halogen or CF.sub.3.

Abstract: Described is a triazole derivative represented by the formula (1): wherein R represents a hydrogen atom, an alkyl group, an aralkyl group or an acyl group, n stands for 0 to 2 and m stands for 1 to 5 or salt thereof, and a pharmaceutical containing the derivative or salt as an effective ingredient.

Abstract: An electrophotographic photoconductor is composed of an electroconductive support and a photoconductive layer formed thereon which contains a charge generating material and a charge transporting material. The charge generating material is composed of a particular triasazo compound and a particular disazo compound. A photoconductive composition useful as a photoconductive material is also composed of the trisazo compound and the disazo compound.

Abstract: An electrophotographic copying apparatus is provided with a belt-shaped photoconductor comprising. A magnetic electroconductive support and a photoconductive layer are formed on the photoconduction. A magnetic cleaning member is positioned for cleaning the surface of the belt-shaped photoconductor.

Abstract: An electrostatic latent image developing apparatus has a developing sleeve, an agitating roller rotatable in the same direction as the developing sleeve and a magnetic device fixedly provided within the developing sleeve and having a plurality of N and S poles which include auxiliary poles of the same polarity adjacent to each other circumferentially of the sleeve and opposed to the agitating roller. A developer restraining plate between the developing sleeve and the agitating roller has a first guide surface for guiding the developer supplied by the agitating roller and a second guide surface for limiting the developer used from moving toward the sleeve portion to which the developer is supplied by the agitating roller.